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doi:10.1016/j.kjms.2011.05.005Abstract Speciation analysis of trace elements is an important issue in biomedical and
toxicological sciences because different elemental species have different effects on health
and the environment. For humans, arsenic (As) is a toxic element; the toxicity of As compounds
is highly dependent on its chemical form. Although inorganic As compounds are human carcin-
ogens, organic arsenicals are relatively less toxic. This article deals with recent advances and
applications of methods for As speciation in biomedical sciences, with emphasis on the
specimens commonly encountered in biomedical laboratories.
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Arsenic (As) is well known as a toxic element for human
beings. The International Agency for Research on Cancer
has classified As and its inorganic compounds as “carcino-
genic to human” (Group 1); the organic arsenicals mono-
methylarsonic acid (MMA) and dimethylarsinic acid (DMA)
are classified as “possibly carcinogenic to humans” (Group
2B); arsenobetaine (AsB) and other organic compounds that
are not metabolized in humans are “not classifiable”
(Group 3) [1,2]. Chronic As poisoning is a serious publicnt of Medical Laboratory
Medical University, No. 100,
aiwan.
w (Y.-L. Huang).
vier Taiwan LLC. All rights reservhealth problem worldwide; long-term exposure to inorganic
As from drinking water is associated with skin lesions and
malignant diseases [3e5].
As is a ubiquitous element that ranks 12th in abundance
in the human body. Despite its notorious reputation as
a poison, As has been used as a therapeutic agent for more
than 2000 years [6]. Recently, As compounds have been
examined extensively as potential anticancer agents
toward some malignant diseases, especially for the treat-
ment of acute promyelocytic leukemia (APL) [7,8], where
low doses of arsenic trioxide was found to induce complete
remission in individuals with APL who had a relapse, sug-
gesting that induction of cell apoptosis might be one of the
mechanisms of the therapeutic effect of arsenic trioxide.
Because of the different toxic effects induced by different
As species, speciation analysis is critical when evaluatinged.
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individuals with APL.
Measurement of essential or toxic elements has tradi-
tionally been performed using atomic spectrometry tech-
niques, most notably flame atomic absorption spectrometry
(AAS), electrothermal AAS, inductively coupled plasma
atomic emission spectrometry, and inductively coupled
plasma mass spectrometry (ICPeMS). ICPeMS is one of the
most common analytical techniques for the determination
of trace elements because of its multi-element analysis
capability and its high sensitivity for most elements
of interest [9]. For separation, high-performance liquid
chromatography (HPLC) has the advantages of greater
versatility and good reproducibility relative to other chro-
matographic separation methods (e.g. gas chromatography
or capillary electrophoresis) [10]. The combination of
HPLC with suitable detection systems for As speciation in
biomedical sciences is the most attractive and most
established approach. Ion-exchange chromatography is the
most widely used separation technique, whereas ICPeMS is
the most commonly used detection method.
The low levels of As species in biomedical matrices make
obtaining sensitive and reliable measurements a true
challenge. ICPeMS provides a low detection limit and good
sensitivity for the detection of trace element species;
combined with the ease of coupling most HPLC systems
with the ICPeMS, it is an excellent detection method for As
speciation analysis. Table 1 lists the common As species
found in biological materials. Because of the complexity of
the sample matrix and the diversity of As species, the
search for suitable analytical methods is a key issue for As
speciation analysis in the field of biomedical sciences; this
article focuses on some significant findings in the area,
focusing on relevant reports published in the calendar years
2005e2009.
Advances and applications of As speciation
analysis in biomedical matrices
Table 2 lists some selected recent (2005e2009) applications
of As speciation in commonly used biomedical matrices.
The analytical systems that have been used for As specia-
tion in biomedical matrices, mainly from human beings,
have typically combined chromatographic separation withTable 1 Arsenic species commonly found in biological material
Name Abbr
Inorganic arsenic species
Arsenite (arsenious acid) As
Arsenate (arsenic acid) As
Organic arsenic species
Monomethylarsonous acid MM
Monomethylarsonic acid MM
Dimethylarsinous acid DM
Dimethylarsinic acid DM
Arsenobetaine As
Arsenocholine As
Trimethylarsine oxide TM
Tetramethylarsonium ion Meelemental or molecular mass spectrometric detection.
Among these analytical systems, HPLC coupled with ICPeMS
has been the most widely used method for determining As
species in biomedical matrices. In the following sections,
we describe the recent applications of As speciation anal-
ysis in urine, blood, hair and nail, and other biomedical
matrices.
As speciation in urine
Most of the method developments and applications of As
speciation analysis in biomedical research have focused on
the analysis of urine, which is generally considered a suit-
able sample for evaluating As metabolism. Notably,
however, most medical laboratories measure only the total
As concentration in urine, presumably because the practi-
tioners are unaware that a high total-As concentration
requires further speciation analysis, which might not be
possible because of the lack of rapid and reliable methods.
For high-throughput speciation in a medical laboratory,
Heitland and Ko¨ster [23] developed and validated a method
using HPLC coupled with ICPeMS for the determination of
five As species in human urine. They applied this method to
compare urinary As speciation for various medical cases
[22], suggesting that real concentration data for As species
in urine are helpful for toxicologists and hygienists
to understand the impact of As species in different situa-
tions. HPLCehydride generation (HG)eICPeMS, HPLCeHGe
atomic fluorescence spectrometry (AFS), and HGeAAS are
the three most commonly used analytical methods for
determination of inorganic As and its metabolites in urine.
From a comparison of the performance of these three
methods, Lindberg et al. [18] suggested that, because of its
considerably lower costs, HPLCeHGeAFS might be a good
alternative in laboratories where the high cost of ICPeMS
is not justified in relation to the intended use of the
instrument.
Occupational and environmental exposure to As
compounds is associated with the increased prevalence of
various kinds of diseases. Analytical methods for monitoring
occupational or environmental exposure have focused on
the determination of As metabolites in urine. Morton and
Mason [54] developed an anion-exchange-based method
coupled with ICPeMS that they subsequently used tos
eviation Chemical formula
(III) As(OH)3
(V) AsO(OH)3
A(III) CH3As(OH)2
A(V) CH3AsO(OH)2
A(III) (CH3)2AsOH
A(V) (CH3)2AsO(OH)
B (CH3)3As
þCH2COO
e
C (CH3)3As
þCH2CH2OH
AO (CH3)3AsO
4As
þ (CH3)4As
þ
384 K.-C. Hsu et al.establish the levels of five As species in urine in unexposed
and exposed persons. They found that urine samples from
workers involved in timber treatment exhibited signifi-
cantly higher levels of As(III), As(V), MMA, and DMA than did
those from both unexposed groups and workers in the
semiconductor industry. Using HPLCeICPeMS, Christian
et al. [12] investigated the relationship between urinary
As and Se excretion in pregnant women living in an As-con-
taminated region of Chile. They suggested that in pop-
ulations exposed to As, Se intake might be correlated with
urinary As excretion and may alter As methylation. Although
chronic As exposure may not be rare in humans, subacute As
poisoning is not common. Xu et al. [37] described the clin-
ical manifestations and levels of As methylation after a rare
subacute As-poisoning accident of workers who ingested
high levels of As caused by a pipe leakage in a copper
smelting factory. Studies of excreted urinary As species
determined using HGeAAS with cold trapping reported
increased urinary excretion of MMA and inorganic As
compared with controls and concluded that biomethylation
of As decreased in a dose-rate-dependent manner.
Studies of dietary intake of As and its metabolism have
gained much attention when using novel sample pretreat-
ment methods coupled with ICPeMS. Many recent studies
have examined As species in human urine in relation to
dietary exposure. Using HPLC coupled with ICPeMS, Raml
et al. [35] identified seven As metabolites in human urine
after ingestion of an oxo-arsenosugar. In addition to
previously identified metabolites, they reported three new
As metabolites. By monitoring As metabolites using
HPLCeICPeMS, Schmeisser et al. [39] investigated the As
species excreted in urine after consumption of arsenolipids,
significant As constituents of some seafood products, con-
tained in commercially available canned cod liver products.
Their study of two human volunteers provided data
revealing that the arsenolipids present in cod liver are
metabolized and excreted almost quantitatively in urine,
chiefly as DMA and four As-containing fatty acids. Pearson
et al. [55] described a method for the rapid separation of
five As species [As(III), AsB, DMA, MMA, and As(V)] for
subsequent quantitative determination using ICPeMS. The
species were separated on a monolithic silica column using
a mobile phase comprising tetrabutylammonium bromide,
phosphate buffer, and methanol. They found a significant
increase in DMA excretion in urine after rice consumption.
Hata et al. [56] used HPLC coupled with ICPeMS for the
quantitative determination of As(III), As(V), DMA, MMA, and
AsB in urine samples from Japanese volunteers. They found
that the mean and range of values for DMA and AsB were
significantly higher than those reported for Western pop-
ulations, presumably because of the high seafood
consumption of the Japanese population. In contrast to
most previous studies that have identified seafood as
a significant contributor to the urinary excretion of As, Sirot
et al. [25] found no correlation between dietary exposure
and levels of urine biomarkers for As in a study of a French
population with a high consumption of seafood. They sug-
gested that biological monitoring results should be inter-
preted with caution.
The main advantage of ion-pair HPLC is that it facilitates
the separation of ionic species and uncharged molecular
species. Table 2 reveals that, with the exception of ion-exchange HPLC, ion-pair HPLC has been the most widely
used separation technique for biomedical As speciation in
recent years. Using ion-pair liquid chromatography (LC)
coupled with ICPeMS, Pan et al. [32] developed a method
for the separation and simultaneous determination of six As
species [As(III), As(V), DMA, MMA, arsenocholine, and AsB]
in human urine; this process featured a simple sample
preparation method involving filtering through a 0.45-mm
membrane and dilution with the mobile phase. Rabeih
et al. [34] described a method for the determination of six
As species [arsenite, arsenate, DMA(III), DMA(V), MMA(III),
and MMA(V)] in human urine using ion-pair reversed-phase
HPLC with isocratic elution coupled with ICPeMS. They
used this technique to quantify As speciation in children’s
urine samples obtained from an As-affected area in Brazil.
To overcome the cost and time limitations, Afton et al. [31]
developed a multi-element speciation method for the
simultaneous speciation of As and Se. Based on ion-paired
reversed phase chromatography followed by ICPeMS and
electrospray ionization (ESI) ion-trap MS, they identified
and quantified four As [As(III), As(V), MMA(V), and DMA(V)]
and four Se species in various matrices, including urine
samples, using tetrabutylammonium hydroxide as the ion-
pairing agent.
The discrimination of As species in normal individuals
and in diseased individuals is important for the evaluation
of the therapeutic or toxicological effects of As compounds.
To characterize inter- and intraindividual variabilities in the
urine As metabolites of healthy individuals, Kile et al. [15]
used HPLCeHGeAAS to determine several As species
[As(III), As(V), DMA, and MMA] in urine samples collected
from Bangladeshi individuals exposed to As in drinking
water. They reported that concentrations of the urinary As
metabolites were fairly reproducible within individuals but
were poorly reproducible when expressed as ratios, sug-
gesting that epidemiological studies should use both
urinary As concentrations and the relative proportion of
urinary As metabolites to minimize measurement errors
and to facilitate the interpretation of the factors that
influence As metabolism. Huang et al. [14] examined the
association between urinary As speciation and the inci-
dence of urothelial carcinoma in a cohort study. They used
HPLCeHGeAAS method to measure As(III), As(V), MMA, and
DMA in urine samples collected from a total of 1,078 resi-
dents of southwest Taiwan, finding that individuals diag-
nosed with urothelial cancer had greater percentages of
MMA and lower percentages of DMA compared with the
healthy individuals. A significant association existed
between inefficient As methylation and the development of
urothelial cancer in areas featuring high cumulative As-
exposure strata in a region of southwest Taiwan endemic
for arseniasis. Using the same method to measure the four
As species of interest, Huang et al. [16] also investigated
the association between As exposure and the risk of carotid
atherosclerosis in a sample of the Taiwanese population.
They concluded that individuals with greater exposure to As
and a lower capacity to methylate inorganic As may be at
a higher risk to develop carotid atherosclerosis.
Several novel approaches developed for As speciation
have been applied to urine samples. Zhu et al. [17] devel-
oped a novel hybrid atomizer based on atmospheric pres-
sure dielectric barrier discharge plasma. The coupling of
Arsenic speciation in biomedical sciences 385HPLC with HGeAAS and the optimized dielectric barrier
discharge atomizer provided results for the speciation of
As in NIST SRM-2670a (standard reference materials 2670a,
human urine) urine that were in good agreement with those
obtained using ICPeMS. Although photooxidation is
a potential means for the conversion of organic As species,Table 2 Separation and detection systems used for arsenic spe
Sample type Arsenic species
Urine
As(III), As(V), MMA, DMA Anion
As(III), As(V), MMA, DMA Anion
As(III), As(V), MMA, DMA Anion
As(III), As(V), MMA, DMA Anion
As(III), As(V), MMA, DMA Anion
As(III), As(V), MMA, DMA Anion
As(III), As(V), MMA, DMA Anion
As(III), As(V), MMA, DMA, AsB Anion
As(III), As(V), MMA(V), DMA(V), AsB Anion
As(III), As(V), MMA, DMA, AsB, AsC, TMAO Anion
As(III), As(V), MMA(V), DMA(V), MMA(III),
DMA(III), AsB
Anion
As(III), MMA(V), DMA(V) Ion-pa
As(III), As(V), MMA, DMA Ion-pa
As(III), As(V), DMA, MMA, AsC, AsB Ion-pa
PAA, PMAA, DPAA, PDMAO, DPMAO Ion-pa
As(III), As(V), MMA(V), DMA(V), MMA(III),
DMA(III), AsB, AsC, Tetra (Me4As
þ),
TMAsO
Ion-pa
HPLC
DMA, oxo-DMAE, TMAO, oxo-DMAA,
thio-DMAA, thio-DMAE, thio-arsenosugar
Anion
Thio-Gly, thio-SO4, TMAO, thio-PO4, thio-
DMAE, thio-SO3, thio-DMAA, thio-DMA
Rever
iAs, DMA, MMA, TMA Cryog
As(III), As(V), MMA(V), DMA(V), MMA(III),
DMA(III), AsB
Anion
As(III), As(V), MMA, DMA, AsB, AsC,
TMAO, MPhAs, DPhAs
Cation
DMA, thio-DMAP, oxo-DMAB, thio-DMAB Anion
Blood
Serum As(III), MMA(V), DMA(V) Ion-pa
Serum Inorganic As, DMA, MMA Anion
Plasma,
blood cell
As(III),As(V), MMA(V), DMA(V) Anion
whole blood As(III), As(V), MMA(V), DMA(V), AsB Anion
Hair and nail samples
DPAA Gel-pe
As(III), As(V) Electr
As(III), As(V), MMA, DMA Anion
As(III), As(V), MMA(V), DMA(V) Anion
As(III), As(V), MMA(V), DMA(V) Ion-pa
As(III), As(V), MMA, DMA, AsB Anion
As(III), As(V), MMA, DMA, AsB Anion
As(III), As(V), MMA(V), MMA(III),
DMA(V), DMA(III)
Anion
Sulfur-containing arsenic metabolites Size-ethe reaction times in conventional photooxidation reactors
is relatively long. Nakazato and Tao [38] developed a novel
post-column photooxidation reactor that allows high-
efficiency photooxidation using a low-temperature mercury
lamp. In the absence of any oxidizing agents, the oxidative
decomposition of persistent organic arsenicals (e.g. AsB) tociation in biomedical matrices
Separation system Detection system References
-exchange HPLC HGeICPeMS [11]
-exchange HPLC ICPeMS [12,13]
-exchange HPLC HGeAAS [14e16]
-exchange HPLC HGeDBD [17]
-exchange HPLC HGeAFS,
HGeICPeMS
[18]
- and cation-exchange HPLC ETAAS [19]
-exchange HPLC HGeAFS [20]
-exchange HPLC ICPeMS [21e24]
-exchange HPLC ICPeMS [25e27]
-exchange HPLC ICPeMS [28]
- and cation-exchange HPLC ICPeMS [29]
ir HPLC ICPeMS [30]
ir HPLC ICPeMS [31]
ir HPLC ICPeMS [32]
ir HPLC ICPeMS [33]
ir HPLC, cation-exchange ICPeMS [34]
-exchange HPLC ICPeMS [35]
sed-phase HPLC ICPeMS [36]
enic separation HGeAAS [37]
- and cation-exchange HPLC ICPeMS [29]
-exchange LC HEPO/HGeICPeMS [38]
- and cation-exchange HPLC ICPeMS [39]
ir HPLC ICPeMS [30]
, cation-exchange HPLC ICPeMS [13]
-exchange HPLC ICPeMS, HGAFS [40]
-exchange HPLC ICPeMS [27]
rmeation HPLC ICPeMS [41]
ochemical HGeAAS [42]
-exchange HPLC ICPeMS [43,44]
-exchange HPLC ICPeMS [45]
ir HPLC HGeICPeMS [46]
-exchange HPLC ICPeMS [24]
- and cation-exchange HPLC ICPeMS [47]
- and cation-exchange HPLC ICPeMS [48]
xclusion HPLC ICPeMS [49]
(continued on next page)
Table 2 (continued)
Sample type Arsenic species Separation system Detection system References
Other biomedical matrices
Saliva As(III), As(V), MMA(V), DMA(V) Reversed-phase, anion, cation-
exchange HPLC
ICPeMS [50]
Bladder
epithelial cell
Inorganic As, MMA, DMA Cryotrapping HGeCTeAAS [51]
Hepatocyte As(III), As(V), MMA(V), DMA(V), AsB, AsC Anion-exchange HPLC ICPeMS [52]
Fecal Me2AsSH, Me2AsSMe, Me2AsSSMe,
(Me2AsO2S, MeAs(SMe)(SEt)
Gas chromatography ICPeMS [53]
AASZ Atomic absorption spectrometry; DBDZ Dielectric barrier discharge; DMAAZ Dimethylarsinoylacetate; DMAEZ Dimethylarsi-
noylethanol; DPAAZ Diphenylmethylarsinic acid; DPhAsZ Diphenylarsinic acid; DPMAOZ Phenyldimethylarsine oxide; ETAASZ
Electrothermal atomic absorption spectrometry; HEPOZHigh-efficiency photooxidation; HGAFSZHydride generation atomic
fluorescence spectrometry; MPhAsZMonophenylarsonic acid; PAAZ Phenylarsonic acid; PDMAOZ Phenylmethylarsine oxide;
PMAAZ Phenylmethylarsinic acid; Thio-GlyZ Thio-arsenosugarglycerol; TMAsOZ Trimethylarsine oxide.
386 K.-C. Hsu et al.arsenate occurs within an extremely short time (3.5
seconds). In addition, incorporating nanomaterials into the
analytical system, Sun et al. [11] developed a novel diges-
tion method for the determination of urinary As species
using on-line nano-TiO2-catalyzed photooxidation coupled
between microbore LC and ICPeMS. This method was
applied for the determination of As(III), MMA, DMA, and
AS(V) in urine samples.
As speciation in blood
Most As speciation analyses of blood sources are commonly
performed using ion chromatography coupled with ICPeMS
to achieve the lowest detection levels from different
matrix types. Arsenite, arsenate, MMA, DMA, AsB, arsen-
ocholine, and other possible organic As species have all
been determined this way. In recent studies of the speci-
ation of As species in blood samples, determining the
effects of As compounds as therapeutic drugs for leukemia
has become a dominant issue. Fukai et al. [30] used
HPLCeICPeMS to monitor the levels of serum and urine As
[As(III), MMA, and DMA] in an individual with APL who was
administered arsenic trioxide as a therapeutic agent. They
concluded that nanomolar concentrations of As in serum
were sufficient to produce a therapeutic effect against APL.
Fujisawa et al. [57] also used HPLCeICPeMS to monitor
plasma As and urinary As excretion after therapeutic
administration of arsenic trioxide to individuals with APL.
After intravenous administration, the methylated As
species were rapidly excreted in the urine, with no
measurable accumulation of arsenic trioxide in the blood.
Sample preparation for As speciation is an important
issue because potential artifacts may be presented after
the preparation and storage of biological samples. To study
analytical artifacts in the speciation of As in clinical
samples, Slejkovec et al. [40] used HPLCeHGeAFS and
HPLCeICPeMS to analyze blood samples from cancer indi-
viduals treated with high doses of arsenic trioxide. Because
contemporary analytical protocols might not be completely
immune to artifacts resulting from losses arising from the
sampling to the detection stage, they recommended care-
ful interpretation of the results, particularly regarding
metabolic and pharmacokinetic effects, and independentcomparison of the sum of species with the total As
concentration.
As speciation in hair and nail samples
The convenient and noninvasive sampling of hair and nails is
frequently applied to the biological monitoring of metal
exposure. Analysis of As in human hair is commonly used for
biomedical and epidemiological applications to assess expo-
sure or therapeutic outcomes. Recently, speciation analysis
of As inhair, fingernail, and toenail sampleshasbecomeanew
approach and powerful tool for analytical assessment in
studies of As exposure [26,42e44,46,48]. Ya´n˜es et al. [46]
developed a simple method for As speciation in human hair
based on water extraction and HPLCeHGeICPeMS. From
assessments of representative species in extracts from hair,
they found that more than 98% of the total As in hair was
inorganic As. Raab and Feldmann [48] described a new
method for As speciation in hair by extracting with boiling
water; they used it to investigate the stability of As species
during extraction from hair and nail matrices. Under the
extraction conditions used, they noted that inorganic and
methylated As(V) species were stable, but methylated As(III)
species were not. Furthermore, hair and nail samples from
humans suffering from chronic As intoxication contained
predominantly inorganic As, with small and strongly varying
amounts of DMA(V) and MMA(V) present. Sanz et al. [44] used
pressurized liquid extraction of As from hair and then per-
formed As speciation analysis using HPLCeICPeMS. They
validated these methods by analyzing a certified human hair
reference material. The concentrations found in hair and
nails coming from a heavily As-contaminated area were
significantly higher (39-fold and 20-fold, respectively) than
their background levels. A similar study, conducted by Button
et al. [45], on theHPLCeICPeMSanalyses of aqueous extracts
fromtoenail samples revealed that inorganicarsenitewas the
dominant species extracted,with lesser amounts of inorganic
arsenate and organic dimethylarsinate. Li et al. [42] devel-
oped a method for direct determination of trace levels of
As(III) and As(V) through electrochemical HGeAAS without
prereduction of As(V). Their method, based on electro-
chemical HGeAAS with a glassy carbon cathode, led to the
simultaneous generation of AsH3 from As(III) and As(V) in the
Arsenic speciation in biomedical sciences 387presence of acid. Quantitation of these two As species in
a certified human hair reference material was possible by
controlling the electrolytic current.
To investigate As metabolism through a comparative
study of As levels in biological matrices, Brima et al. [24]
determined the levels of total As in urine, fingernail, and
hair samples and those of As metabolites in the urine of
healthy volunteers from three different ethnic groups
residing in the same area; they observed statistically
significant differences, except for the As content in hair.
Mandal et al. [49] used size-exclusion HPLCeICPeMS to
identify sulfur-containing As metabolites in biological
samples. For the identification of four thioarsenical
compounds in human nail and urine samples, the proposed
Size exclusion chromatographyeESIeMS technique provided
better results when compared with those obtained through
anion-exchange HPLCeICPeMS. A recent report has sug-
gested that Napoleon Bonaparte’s death was brought on by
chronic exposure to As and a medication error; Kintz et al.
[47] used HPLCeICPeMS to perform As speciation in two
samples of Napoleon’s hair. Their results identified massive
amounts of inorganic As, which the authors considered to
be consistent with chronic As intoxication.As speciation in other body fluids and biological
matrices
Although the value of salivary trace element measurements
for the biomonitoring of exposure has been questioned by
researchers for many years, saliva has continued to attract
attention as a noninvasive matrix. As speciation analysis in
saliva is potentially useful for evaluating human exposure
and exploring As metabolism.
Yuan et al. [50] separated As species in saliva using LC
and quantified them through ICPeMS. They determined
several As species [As(III), As(V), DMA, and MMA] in saliva
using LCeICPeMS and then confirmed the identity of the
species using ESI MS/MS. They found a statistically signifi-
cant relationship between the salivary As concentration
and the presence of As-induced skin lesions; the salivary As
concentrations also correlated with the drinking-water As
concentration. The authors concluded that speciation of
As(III), As(V), DMA, and MMA in human saliva is a useful
method for monitoring As exposure.
The cell culture model for demonstrating the possible
effects of As intoxication has gained much attention in
recent years; speciation analysis has, therefore, become
necessary for studying the metabolism of As compounds.
Herna´ndez-Zavala et al. [51] investigated the speciation of
As in exfoliated bladder epithelial cells from individuals
exposed to As in drinking water. Using HGecryotrappinge
AAS to determine the concentrations of inorganic As, MMA,
and DMA, they observed detectable concentrations of all
three species in both urine and epithelial cells. The authors
suggested that urinary levels of inorganic metabolites do
not necessarily reflect the levels of these metabolites in
the bladder epithelium because no correlation existed
between the concentrations of the species in the two
sample types. Thus, As speciation analysis in bladder
epithelial cells may be an effective tool for risk assessment
of bladder cancer and other urothelial diseases associatedwith exposure to inorganic As. Cao et al. [52] used HPLC
coupled with ICPeMS to determine the levels of total As
and As metabolites in human liver hepatocytes. Relative
to direct sampling, they compared the effects of three
digestion methods in the determination of As in liver
hepatocytes after ultrasonication. Speciation of the lysate
using HPLCeICPeMS revealed the presence of As(III), As(V),
DMA, and a DMA intermediate metabolite.
The application of microorganisms in trace element
speciation is an interesting and alternative technology.
The ability of cecal microflora to methylate inorganic As
species has been described; Harrington et al. [58] studied
the anaerobic and aerobic degradation of AsB by micro-
organisms associated with the human large intestine. They
used HPLCeICPeMS to determine the levels of total As and
As species in samples obtained from the 30-day incubation
of human fecal matter with the microorganisms. Analysis
of the aerobic system revealed significant degradation of
AsB to DMA, dimethylarsinoylacetate, and trimethylarsine
oxide after 7 days; in contrast, the anaerobic system
exhibited no AsB degradation. The authors correlated
these results with the biocatalytic ability of AsB degra-
dation within the human GI tracts. Diaz-Bone et al. [53]
analyzed the volatile As compounds formed from intestinal
microorganisms, using simultaneous electron-impacte
MS and ICPeMS detection after gas chromatographic
separation to rapidly identify volatile As species in the
headspace of fecal incubations. They identified three
As speciesdmethylmethylthioethylthioarsine, dimethylme-
thylselenoarsine, and thiobis(dimethylarsine)dthat had
not been reported previously from either human or envi-
ronmental matrices, concluding that the intestinal
metabolism of As is a process that should be considered
during the risk assessment of ingested As.
Conclusion and future trends
The importance of As speciation analysis in biomedical
fields will continue to grow because of potential exposure
to or contamination from As compounds and because of the
potential applications of certain As compounds in cancer
therapy. Although chromatographic separation coupled
with ICPeMS detection has been used predominantly for As
speciation analysis in biomedical research, some efforts
have been undertaken to develop nonchromatographic
speciation approaches. Methodological developments for As
speciation have resulted in new hyphenation techniques
and new detection systems. Overcoming the obstacles
posed by low As levels, complicated matrices, and high
diversity of As species in biomedical specimens remains
a great challenge for As speciation and is facilitating the
development of novel hyphenated methods. In addition,
investigating As metabolism through speciation analysis of
bodily fluids (e.g. saliva, sweat, or cerebrospinal fluid)
appears to be a new trend awaiting further investigation.
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